Showing results (101-110 of 481) with videos related to
Sort By:
Pageof 49
Journal of the American Heart Association|May 3, 2014
The incidence of kidney injury for patients treated with a high-potency versus moderate-potency statin regimen after an acute coronary syndromeAmy Sarma, Christopher P Cannon, James de Lemos, et al.JAMA Cardiology|March 15, 2017
Long-term Low-Density Lipoprotein Cholesterol-Lowering Efficacy, Persistence, and Safety of Evolocumab in Treatment of Hypercholesterolemia: Results Up to 4 Years From the Open-Label OSLER-1 Extension StudyMichael J Koren, Marc S Sabatine, Robert P Giugliano, et al.Circulation|July 19, 2006
Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor TrialDavid A Morrow, James A de Lemos, Marc S Sabatine, et al.Circulation|September 13, 2017
Timing of Angiography and Outcomes in High-Risk Patients With Non-ST-Segment-Elevation Myocardial Infarction Managed Invasively: Insights From the TAO Trial (Treatment of Acute Coronary Syndrome With Otamixaban)Pierre Deharo, Gregory Ducrocq, Christoph Bode, et al.JACC. Cardiovascular Interventions|November 19, 2013
Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38)Oluseyi Ojeifo, Stephen D Wiviott, Elliott M Antman, et al.JAMA Cardiology|July 15, 2026
Development and Validation of a Simplified Martin-Hopkins LDL-C Equation Using Machine LearningJihwan Park, Leon Fan, Mark A Marzinke, et al.European Heart Journal|December 19, 2018
Persistent arterial wall inflammation in patients with elevated lipoprotein(a) despite strong low-density lipoprotein cholesterol reduction by proprotein convertase subtilisin/kexin type 9 antibody treatmentLotte C A Stiekema, Erik S G Stroes, Simone L Verweij, et al.Journal of Thrombosis and Thrombolysis|July 13, 2007
Angiographic perfusion score in patients treated with PCI at late angiography following fibrinolytic administration for ST-segment elevation myocardial infarction is associated with morbidity and mortality at 30 daysYuri B Pride, Jacqueline L Buros, Erin Lord, et al.Journal of the American College of Cardiology|July 21, 2004
B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudyJessica L Mega, David A Morrow, James A De Lemos, et al.Journal of the American College of Cardiology|March 14, 2020
Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary SyndromeBenjamin M Scirica, Brian A Bergmark, David A Morrow, et al.Pageof 49